Pathogen safety of Prolastin® Source: Eur Respir J 2006; 28: Suppl. 50, 518s Year: 2006
Post marketing surveillance for the salmeterol/fluticasone combination product Source: Eur Respir J 2005; 26: Suppl. 49, 382s Year: 2005
Efficacy and safety of omalizumab in real-life practice in India Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
Post Marketing Surveillance to evaluate the safety and effectiveness of Umeclidinuim Bromide in Korean patients with COPD Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Use and safety of histamine challenge testing in clinical practice Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002
Clinical efficacy and safety of medical thoracoscopy Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Evaluation of the tolerability of the dornase alfa based on the results of a multicenter scientific program of post-marketing use of the medicine Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021
Real-world effectiveness and cost-effectiveness of asthma step-up options: A UK comparison of extrafine hydrofluoroalkane-beclometasone and combination therapy Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013
Improvement patient safety during lung function testing through the implementation of a safety checklist Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020
Confirmed clinical safety and efficacy of grass allergen tablets Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005
A randomised controlled trial comparing the immunogenicity, safety and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a needless injector device versus a traditional pre-filled syringe and needle Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
An evaluation of the safety, efficacy and cost-effectiveness for patients with acute respiratory illness, of a community-based intravenous medication service: The first 26 months Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011
Safety, tolerability and efficacy of linezolid for the treatment of M/XDR-TB: A systematic review and meta-analysis Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Safety and efficacy of NVA237 once daily in Japanese patients: The GLOW4 trial Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
A post-marketing study to evaluate the safety and tolerability of a non-chlorofluorocarbon salbutamol inhaler in asthmatic patients in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 78s Year: 2002
Safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of GSK573719 inhalation powder in healthy subjects Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
Safety and pharmacokinetics of nintedanib plus sildenafil in the INSTAGE trial Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019
Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019
Local research ethics committee's approval of the MRC/BTS multicentre intra-pleural streptokinase trial in empyema (MIST - ICTN 39138989) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001